It was observed that β-arrestin2 knockout promoted the HCC progression, and activation of β2-AR regulates two major signaling pathways: PI3K/Akt and MEK/ERK1/2, which are involved in the occurrence and infiltration of HCC 18,19. Here, AKT1 is linked to hepatocellular carcinoma.